RESUMO
Twenty patients with a prosthetic valve (Ionescu-Shiley or Bjork-Shiley) in the aortic position were studied for evidence of intravascular hemolysis. Serum lactic dehydrogenase and serum haptoglobin levels were used as the most sensitive indicators of hemolysis. Elevated concentrations of lactic dehydrogenase were found in all 10 patients with an Ionescu-Shiley prosthesis (mean 402 IU/liter) and in 7 of 10 patients with a Bjork-Shiley prosthesis (mean 234 IU/liter). The mean serum haptoglobin was 15 mg/dl (range 10 to 28) in patients with the Ionescu-Shiley valve and 96 mg/dl (15 to 284) for those with the Bjork-Shiley valve. This study indicates the presence of chronic intravascular hemolysis in patients with the Ionescu-Shiley aortic valve. The increase in lactic dehydrogenase was significantly greater in patients with the Ionescu-Shiley prosthesis than in those with the Bjork-Shiley prosthesis, indicating a slightly shorter red cell life span in the former group.
Assuntos
Valva Aórtica/transplante , Bioprótese , Próteses Valvulares Cardíacas , Hemólise , Adulto , Idoso , Contagem de Células Sanguíneas , Doença Crônica , Feminino , Haptoglobinas , Hemoglobinas , Humanos , L-Lactato Desidrogenase/sangue , Masculino , Pessoa de Meia-Idade , ReticulócitosRESUMO
In this report clinical and angiographic data on three patients with total occlusion of the left main coronary artery is presented. Two of our cases demonstrated rich collateralization with good preservation of left ventricular (LV) function. The third case, with initial subtotal occlusion and no collaterals, sustained a severe anterolateral myocardial infarction (MI) responding to the use of the intra-aortic balloon pump (IABP). This report is consistent with the findings of others who suggest the possible beneficial effect of collaterals in preserving myocardial contractility in this unusual situation. We suggest that the IABP may be of benefit in patients with total occlusion of the left main coronary artery and sparse collaterals who remain unstable and cannot be operated on immediately.
Assuntos
Doença das Coronárias/diagnóstico , Adulto , Angina Pectoris/diagnóstico , Cateterismo Cardíaco , Circulação Colateral , Angiografia Coronária , Ponte de Artéria Coronária , Circulação Coronária , Doença das Coronárias/diagnóstico por imagem , Doença das Coronárias/terapia , Teste de Esforço , Insuficiência Cardíaca/diagnóstico , Humanos , Balão Intra-Aórtico , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/diagnósticoRESUMO
While the very low thrombogenicity without anticoagulant therapy and generally good durability of the lonescu-Shiley bioprosthesis has been demonstrated, further hemodynamic assessment is necessary. The present study assessed cardiac function and heterograft performance during right and left heart catheterization at rest and exercise (three to six months postoperation) of eight patients with severe mitral stenosis and/or regurgitation prior to surgery. We found, comparing pre- and postoperative resting values, that mean pulmonary artery pressure decreased (32 +/- 2.7 to 22 +/- 3.5 mm Hg; P < 0.02), cardiac index increased (2.1 +/- 0.09 to 2.5 +/- 0.13 liters/min/m2; P < 0.01), pulmonary wedge pressure decreased (21 +/- 2.3 to 13 +/- 1.8 mm Hg; P < 0.01), and the clinical status (NYHA) improved markedly. Mean diastolic gradient across the pericardial xenograft was 6.1 +/- 1.1 mm Hg at rest and 14.6 +/- 2.3 mm Hg on exercise. The calculated xenograft surface area was 1.7 cm2 at rest and 2.0 cm2 during exercise. No regurgitation was detected in seven of eight patients. Thus, mitral lonescu-Shiley bioprosthesis provide excellent heterograft function.